Arachnid Labs Limited 08525451 the production of electronic equipment false 1 October 2023 08525451 2023-10-01 2024-09-30 08525451 2023-09-30 08525451 2024-09-30 08525451 2022-10-01 2023-09-30 08525451 2022-09-30 08525451 2023-09-30 08525451 frs102-bus:FRS102 2023-10-01 2024-09-30 08525451 frs102-bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 08525451 frs102-bus:FullAccounts 2023-10-01 2024-09-30 08525451 frs102-bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 08525451 frs102-core:CurrentFinancialInstruments 2024-09-30 08525451 frs102-core:CurrentFinancialInstruments 2023-09-30 08525451 frs102-core:ShareCapital 2024-09-30 08525451 frs102-core:ShareCapital 2023-09-30 08525451 frs102-core:RetainedEarningsAccumulatedLosses 2024-09-30 08525451 frs102-core:RetainedEarningsAccumulatedLosses 2023-09-30 08525451 frs102-bus:Director1 2023-10-01 2024-09-30 08525451 frs102-core:ToolsEquipment 2023-10-01 2024-09-30 08525451 frs102-core:Non-standardPPEClass3ComponentTotalPropertyPlantEquipment 2023-09-30 08525451 frs102-core:Non-standardPPEClass3ComponentTotalPropertyPlantEquipment 2024-09-30 08525451 frs102-core:Non-standardPPEClass3ComponentTotalPropertyPlantEquipment 2023-10-01 2024-09-30 08525451 frs102-core:Non-standardPPEClass3ComponentTotalPropertyPlantEquipment 2023-09-30 xbrli:pure iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares

| Registered number
| 08525451

| Arachnid Labs Limited |
| Unaudited Accounts |
| for the year ended |
| 30 September 2024 |

Arachnid Labs Limited Balance Sheet as at 30 September 2024
| Notes |  | 2024 £ |  | 2023 £
--- | --- | --- | --- | --- | ---
Fixed assets |  |  |  |  |
Tangible assets | 3 |  | 937 |  | 1,406
|  |  | 937 |  | 1,406
Current assets |  |  |  |  |
Debtors | 4 | 0 |  | 216 |
Cash at bank and in hand |  | 83,470 |  | 84,015 |
|  | 83,470 |  | 84,231 |
Creditors: amounts falling due within one year | 5 | (3,546) |  | (3,046) |
Net current assets / (liabilities) |  |  | 79,924 |  | 81,185
Total assets less current liabilities |  |  | 80,861 |  | 82,591
Provisions for liabilities |  |  | (0) |  | (0)
Accruals and deferred income |  |  | (300) |  | (300)
Total net assets (liabilities) |  |  | 80,561 |  | 82,291
Capital and reserves |  |  |  |  |
Called up share capital |  |  | 3 |  | 3
Profit and loss account |  |  | 80,558 |  | 82,288
Shareholders' funds |  |  | 80,561 |  | 82,291

Arachnid Labs Limited
Balance Sheet
as at 30 September 2024

These accounts have been prepared and delivered in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

The directors have not delivered a copy of the company's Profit and Loss account as permitted by s444(5A) of the Companies Act 2006.

For the year ending 30 September 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Signed on behalf of the board of directors

...............................

Mr N Johnson

Director

Approved by the board on 20 June 2025

Company Number: 08525451 (a Private Company Limited by Shares registered in England and Wales)

Registered Office:

483 Green Lanes
London
N13 4BS
England

Arachnid Labs Limited
Notes to the Accounts
for the year ended 30 September 2024

1. | Accounting policies
--- | ---
| Basis of preparation of financial statements These financial statements have been prepared under the historic cost convention in accordance with the accounting policies set out below and with section 1A of FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland, and the Companies Act 2006. The presentation currency is sterling.

| Going concern basis
--- | ---
| The accounts have been prepared on the assumption that the company is able to carry on business as a going concern for the foreseeable future.

| Revenue recognition
--- | ---
| Revenue is measured at the fair value of the consideration received or receivable. Revenue is reduced for estimated customer returns, rebates and other similar allowances.

| Tangible fixed assets depreciation policy
--- | ---
| Tangible fixed assets are stated at cost less accumulated depreciation and impairment losses. Depreciation is provided, after taking account of any grants receivable, at rates calculated to write off the cost of fixed assets, less the estimated residual value, over their estimated useful lives.
Equipment | 25% Straight Line

| Financial instruments
--- | ---
| Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares that are measured at fair value. Derivative financial instruments are initially recorded at cost and thereafter at fair value. All changes in fair value are recognised in the profit or loss account in the period in which they occurred.

2. | Employees
--- | ---
|  | 2024 |  | 2023
| Average number of employees during the period | 0 |  | 0

3. | Tangible fixed assets
--- | ---
|  | Equipment |  | Total
| Cost or valuation | £ |  | £
| At 1 October 2023 | 1,875 |  | 1,875
| At 30 September 2024 | 1,875 |  | 1,875
| Depreciation |  |
| At 1 October 2023 | 469 |  | 469
| Charge for the period | 469 |  | 469
| At 30 September 2024 | 938 |  | 938
| Net book value |  |
| At 30 September 2024 | 937 |  | 937
| At 30 September 2023 | 1,406 |  | 1,406

4. | Debtors
--- | ---
|  | 2024 |  | 2023
|  | £ |  | £
| Other debtors | 0 |  | 216
|  | 0 |  | 216

5. | Creditors: amounts falling due within one year
--- | ---
|  | 2024 |  | 2023
|  | £ |  | £
| Other creditors | 3,546 |  | 3,046
|  | 3,546 |  | 3,046